301520 万邦医药
已收盘 06-30 15:00:00
资讯
新帖
简况
6月30日万邦医药（301520）龙虎榜数据：机构净买入954.57万元
证券之星 · 17:47
6月30日万邦医药（301520）龙虎榜数据：机构净买入954.57万元
【机构调研记录】富安达基金调研奥比中光、万邦医药
证券之星 · 08:01
【机构调研记录】富安达基金调研奥比中光、万邦医药
【机构调研记录】天治基金调研万邦医药
证券之星 · 08:01
【机构调研记录】天治基金调研万邦医药
【机构调研记录】前海开源基金调研绿联科技、万邦医药
证券之星 · 08:01
【机构调研记录】前海开源基金调研绿联科技、万邦医药
【私募调研记录】中欧瑞博调研万邦医药
证券之星 · 08:01
【私募调研记录】中欧瑞博调研万邦医药
股市必读：万邦医药（301520）6月29日披露最新机构调研信息
证券之星 · 01:17
股市必读：万邦医药（301520）6月29日披露最新机构调研信息
异动快报：万邦医药（301520）6月29日9点31分触及涨停板
证券之星 · 06-29 09:38
异动快报：万邦医药（301520）6月29日9点31分触及涨停板
万邦医药最新公告：拟收购赛德盛75.52%股权
证券之星 · 06-26
万邦医药最新公告：拟收购赛德盛75.52%股权
万邦医药：拟以3.02亿元收购安徽赛德盛医药科技有限公司75.52%股权
格隆汇 · 06-26
万邦医药：拟以3.02亿元收购安徽赛德盛医药科技有限公司75.52%股权
万邦医药（301520）披露公司控制的合伙企业认购私募基金份额进展公告，6月25日股价下跌2.85%
证券之星 · 06-25
万邦医药（301520）披露公司控制的合伙企业认购私募基金份额进展公告，6月25日股价下跌2.85%
万邦医药(301520)6月18日股东户数0.7万户，较上期增加1.82%
证券之星 · 06-23
万邦医药(301520)6月18日股东户数0.7万户，较上期增加1.82%
万邦医药：截止2026年6月18日，公司的股东人数为7,005户
证券之星 · 06-23
万邦医药：截止2026年6月18日，公司的股东人数为7,005户
每周股票复盘：万邦医药（301520）股东户数减少2.62%，户均持股上升
证券之星 · 06-21
每周股票复盘：万邦医药（301520）股东户数减少2.62%，户均持股上升
股市必读：万邦医药(301520)股东户数0.69万户，较上期减少2.62%
证券之星 · 06-16
股市必读：万邦医药(301520)股东户数0.69万户，较上期减少2.62%
万邦医药(301520)5月29日股东户数0.71万户，较上期减少4.84%
证券之星 · 06-03
万邦医药(301520)5月29日股东户数0.71万户，较上期减少4.84%
万邦医药：截止2026年5月29日，公司的股东人数为7,065户
证券之星 · 06-03
万邦医药：截止2026年5月29日，公司的股东人数为7,065户
万邦医药（301520）披露高级管理人员离任公告，6月1日股价上涨1.66%
证券之星 · 06-01
万邦医药（301520）披露高级管理人员离任公告，6月1日股价上涨1.66%
股市必读：万邦医药(301520)股东户数0.74万户，较上期减少3.36%
证券之星 · 05-27
股市必读：万邦医药(301520)股东户数0.74万户，较上期减少3.36%
万邦医药：截止2026年5月20日，公司的股东人数为7,424户
证券之星 · 05-26
万邦医药：截止2026年5月20日，公司的股东人数为7,424户
股市必读：万邦医药(301520)股东户数0.74万户，较上期减少3.36%
证券之星 · 05-26
股市必读：万邦医药(301520)股东户数0.74万户，较上期减少3.36%
公司概况
公司名称：
安徽万邦医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2023-09-25
主营业务：
安徽万邦医药科技股份有限公司的主营业务是药学和临床研究一站式服务。公司的主要产品是临床研究服务、药学研究服务。
发行价格：
67.88
{"stockData":{"symbol":"301520","market":"SZ","secType":"STK","nameCN":"万邦医药","latestPrice":32.5,"timestamp":1782802998000,"preClose":28.26,"halted":0,"volume":14425791,"delay":0,"changeRate":0.15,"floatShares":32698400,"shares":93171400,"eps":0.2611,"marketStatus":"已收盘","change":4.24,"latestTime":"06-30 15:00:00","open":31,"high":33.91,"low":31,"amount":473000000,"amplitude":0.103,"askPrice":32.5,"askSize":33,"bidPrice":32.49,"bidSize":72,"shortable":0,"etf":0,"ttmEps":0.2611,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782869400000},"marketStatusCode":5,"adr":0,"adjPreClose":28.26,"symbolType":"stock","openAndCloseTimeList":[[1782783000000,1782790200000],[1782795600000,1782802800000]],"highLimit":31.09,"lowLimit":25.43,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":93171373,"isCdr":false,"pbRate":1.74,"roa":"--","peRate":124.473382,"roe":"--","epsLYR":0.55,"committee":0.593496,"marketValue":3028000000,"turnoverRate":0.4412,"status":0,"floatMarketCap":1063000000},"requestUrl":"/m/hq/s/301520/wiki","defaultTab":"wiki","newsList":[{"id":"2647820534","title":"6月30日万邦医药（301520）龙虎榜数据：机构净买入954.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647820534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647820534?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:47","pubTimestamp":1782812852,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年6月30日公布的交易公开信息显示，万邦医药因日换手率达到30%的前5只证券，连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年6月30日收盘，万邦医药报收于32.5元，上涨15.0%，换手率44.12%，成交量14.43万手，成交额4.73亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入954.57万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000033045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647588235","title":"【机构调研记录】富安达基金调研奥比中光、万邦医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2647588235","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647588235?lang=zh_cn&edition=full","pubTime":"2026-06-30 08:01","pubTimestamp":1782777694,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及6月29日披露的机构调研信息，富安达基金近期对2家上市公司进行了调研，相关名单如下：1）奥比中光 调研纪要：公司是英伟达全球产业数字化生态布局的重要合作伙伴，多款产品已完成与NVIDIA Jetson Thor等系统级模块的适配与验证，Gemini 335、Gemini 336系列双目3D相机已入驻NVIDIA Isaac Sim机器人仿真开发平台并与Isaac Perceptor集成。2）万邦医药 调研纪要：中国医药研发格局正经历深刻转型，创新药成为增长核心引擎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000008033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647588295","title":"【机构调研记录】天治基金调研万邦医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2647588295","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647588295?lang=zh_cn&edition=full","pubTime":"2026-06-30 08:01","pubTimestamp":1782777690,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及6月29日披露的机构调研信息，天治基金近期对1家上市公司进行了调研，相关名单如下：1）万邦医药 调研纪要：中国医药研发格局正经历深刻转型，创新药成为增长核心引擎。旗下最近一年表现最佳的公募基金产品为天治趋势精选混合，最新单位净值为2.04，近一年增长196.77%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000008028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647884085","title":"【机构调研记录】前海开源基金调研绿联科技、万邦医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2647884085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647884085?lang=zh_cn&edition=full","pubTime":"2026-06-30 08:01","pubTimestamp":1782777683,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及6月29日披露的机构调研信息，前海开源基金近期对2家上市公司进行了调研，相关名单如下：1）绿联科技 绿联科技2026年一季报显示，一季度公司主营收入27.98亿元，同比上升53.42%；归母净利润2.38亿元，同比上升58.14%；扣非净利润2.32亿元，同比上升62.73%；负债率26.22%，投资收益76.26万元，财务费用2636.92万元，毛利率39.26%。2）万邦医药 调研纪要：中国医药研发格局正经历深刻转型，创新药成为增长核心引擎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000008015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301606","301520","BK0214","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647588234","title":"【私募调研记录】中欧瑞博调研万邦医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2647588234","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647588234?lang=zh_cn&edition=full","pubTime":"2026-06-30 08:01","pubTimestamp":1782777660,"startTime":"0","endTime":"0","summary":"根据市场公开信息及6月29日披露的机构调研信息，知名私募中欧瑞博近期对1家上市公司进行了调研，相关名单如下：1）万邦医药 调研纪要：中国医药研发格局正经历深刻转型，创新药成为增长核心引擎。中欧瑞博从事证券私募基金管理业务，专注于二级市场证券投资。取名\"兔子基金\"体现了中欧瑞博敬畏风险的投资文化，并始终把风险防范和管理摆在突出位置。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026063000007968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647306939","title":"股市必读：万邦医药（301520）6月29日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2647306939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647306939?lang=zh_cn&edition=full","pubTime":"2026-06-30 01:17","pubTimestamp":1782753430,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘，万邦医药报收于28.26元，上涨20.0%，涨停，换手率7.43%，成交量2.43万手，成交额6824.77万元。关于赛德盛订单情况：截至2026年一季度，在手订单约2.6亿元；2025年新增订单较2024年增长超60%，2026年一季度新增订单较2025年同期增长超50%；创新药CRO单价有望逐步企稳回升。关于人员配置：赛德盛现有人员约170人，覆盖医学、临床运营及稽查领域；暂无SMO、药物警戒团队；后续将依托万邦医药相关能力构建一体化交付体系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000000907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647086344","title":"异动快报：万邦医药（301520）6月29日9点31分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2647086344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647086344?lang=zh_cn&edition=full","pubTime":"2026-06-29 09:38","pubTimestamp":1782697106,"startTime":"0","endTime":"0","summary":"证券之星6月29日盘中消息，9点31分万邦医药（301520）触及涨停板。其所属行业医疗服务目前下跌。领涨股为百诚医药。该股为减肥药，创新药，医药概念热股，当日减肥药概念上涨0.13%。6月26日的资金流向数据方面，主力资金净流入21.7万元，占总成交额1.46%，游资资金净流入29.84万元，占总成交额2.01%，散户资金净流出51.54万元，占总成交额3.48%。近5日资金流向一览见下表：万邦医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900005057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646351002","title":"万邦医药最新公告：拟收购赛德盛75.52%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2646351002","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646351002?lang=zh_cn&edition=full","pubTime":"2026-06-26 19:19","pubTimestamp":1782472793,"startTime":"0","endTime":"0","summary":"万邦医药(301520.SZ)公告称，公司拟以现金方式收购安徽赛德盛医药科技有限公司（简称“赛德盛”）的75.52%股权，最终确定整体转让价格为3.02亿元。本次交易完成后赛德盛将成为公司控股子公司，纳入公司合并报表范围。通过本次收购，公司将进一步完善在创新药板块的业务布局。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600038651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646359162","title":"万邦医药：拟以3.02亿元收购安徽赛德盛医药科技有限公司75.52%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2646359162","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646359162?lang=zh_cn&edition=full","pubTime":"2026-06-26 18:45","pubTimestamp":1782470725,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0216","159938","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646801217","title":"万邦医药（301520）披露公司控制的合伙企业认购私募基金份额进展公告，6月25日股价下跌2.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646801217","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646801217?lang=zh_cn&edition=full","pubTime":"2026-06-25 23:04","pubTimestamp":1782399857,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，万邦医药报收于24.22元，较前一交易日下跌2.85%，最新总市值为22.57亿元。近日，万邦医药披露《关于公司控制的合伙企业认购私募基金份额的进展公告》。公告显示，公司控制的合肥群象齐鸣企业管理合伙企业参与认购嘉兴隆峰创业投资合伙企业基金份额，认缴出资1,000万元，出资比例11.4943%。基金总认缴出资额增至8,700万元，公司认缴出资额及权利未发生变化。本次新增不影响公司日常经营，不损害公司及中小股东利益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500044761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645788207","title":"万邦医药(301520)6月18日股东户数0.7万户，较上期增加1.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645788207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645788207?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:47","pubTimestamp":1782208036,"startTime":"0","endTime":"0","summary":"证券之星消息，近日万邦医药披露，截至2026年6月18日公司股东户数为7005.0户，较6月10日增加125.0户，增幅为1.82%。在医疗服务行业个股中，万邦医药股东户数低于行业平均水平，截至6月18日，医疗服务行业平均股东户数为4.82万户。从股价来看，2026年6月10日至2026年6月18日，万邦医药区间跌幅为3.44%，在此期间股东户数增加125.0户，增幅为1.82%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300030750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645885584","title":"万邦医药：截止2026年6月18日，公司的股东人数为7,005户","url":"https://stock-news.laohu8.com/highlight/detail?id=2645885584","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645885584?lang=zh_cn&edition=full","pubTime":"2026-06-23 15:04","pubTimestamp":1782198263,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)06月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年六月 18日公司的股东总数是多少？谢谢万邦医药回复：尊敬的投资者您好！截止2026年6月18日，公司的股东人数为7,005户。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300020144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645099841","title":"每周股票复盘：万邦医药（301520）股东户数减少2.62%，户均持股上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2645099841","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645099841?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:52","pubTimestamp":1781985132,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，万邦医药报收于24.4元，较上周的25.09元下跌2.75%。本周，万邦医药6月15日盘中最高价报25.88元。6月18日盘中最低价报23.8元，股价触及近一年最低点。万邦医药当前最新总市值22.73亿元，在医疗服务板块市值排名49/51，在两市A股市值排名4838/5206。本周关注点股本股东变化：股东户数较上期减少2.62%，户均持股数量增至9690.0股股本股东变化股东户数变动截至2026年6月10日，公司股东户数为6880.0户，较5月29日减少185.0户，减幅为2.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100001350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643783095","title":"股市必读：万邦医药(301520)股东户数0.69万户，较上期减少2.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643783095","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643783095?lang=zh_cn&edition=full","pubTime":"2026-06-16 03:50","pubTimestamp":1781553020,"startTime":"0","endTime":"0","summary":"截至2026年6月15日收盘，万邦医药报收于25.19元，上涨0.4%，换手率2.72%，成交量8904.0手，成交额2257.1万元。股本股东变化：截至2026年6月10日，万邦医药股东户数为6880.0户，较5月29日减少185.0户，减幅2.62%。交易信息汇总资金流向6月15日主力资金净流入7.86万元；游资资金净流入274.27万元，占总成交额0.0%；散户资金净流出282.13万元，占总成交额0.0%。户均持股数量由上期的9436.0股增加至9690.0股，户均持股市值为34.52万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600004570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640329908","title":"万邦医药(301520)5月29日股东户数0.71万户，较上期减少4.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640329908","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640329908?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:38","pubTimestamp":1780479525,"startTime":"0","endTime":"0","summary":"证券之星消息，近日万邦医药披露，截至2026年5月29日公司股东户数为7065.0户，较5月20日减少359.0户，减幅为4.84%。在医疗服务行业个股中，万邦医药股东户数低于行业平均水平，截至5月29日，医疗服务行业平均股东户数为4.86万户。从股价来看，2026年5月20日至2026年5月29日，万邦医药区间跌幅为9.17%，在此期间股东户数减少359.0户，减幅为4.84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300035815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640997802","title":"万邦医药：截止2026年5月29日，公司的股东人数为7,065户","url":"https://stock-news.laohu8.com/highlight/detail?id=2640997802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640997802?lang=zh_cn&edition=full","pubTime":"2026-06-03 11:34","pubTimestamp":1780457684,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)06月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年五月 29日公司的股东总数是多少？谢谢万邦医药回复：尊敬的投资者您好！截止2026年5月29日，公司的股东人数为7,065户。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300019835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640329953","title":"万邦医药（301520）披露高级管理人员离任公告，6月1日股价上涨1.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640329953","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640329953?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:21","pubTimestamp":1780309275,"startTime":"0","endTime":"0","summary":"公司于近日披露《关于公司高级管理人员离任的公告》。公告显示，安徽万邦医药科技股份有限公司董事会于2026年5月30日收到公司副总经理周燕女士提交的书面辞职报告，周燕女士因个人原因申请辞去公司副总经理职务。其原定任期至第三届董事会任期届满之日，辞职报告自送达董事会之日起生效。周燕女士已完成工作交接，其离任不会影响公司日常经营活动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100029912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638547499","title":"股市必读：万邦医药(301520)股东户数0.74万户，较上期减少3.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638547499","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638547499?lang=zh_cn&edition=full","pubTime":"2026-05-27 03:37","pubTimestamp":1779824230,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，万邦医药报收于38.65元，下跌2.52%，换手率3.09%，成交量6810.0手，成交额2636.28万元。交易信息汇总资金流向5月26日主力资金净流出34.19万元；游资资金净流入62.4万元；散户资金净流出28.21万元。股本股东变化股东户数变动近日万邦医药披露，截至2026年5月20日公司股东户数为7424.0户，较5月8日减少258.0户，减幅为3.36%。户均持股数量由上期的8678.0股增加至8980.0股，户均持股市值为36.91万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700006013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638559138","title":"万邦医药：截止2026年5月20日，公司的股东人数为7,424户","url":"https://stock-news.laohu8.com/highlight/detail?id=2638559138","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638559138?lang=zh_cn&edition=full","pubTime":"2026-05-26 15:36","pubTimestamp":1779780968,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截至5月20日公司股东人数是多少?谢谢！万邦医药回复：尊敬的投资者您好！截止2026年5月20日，公司的股东人数为7,424户。感谢您的关注！以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600020908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638734554","title":"股市必读：万邦医药(301520)股东户数0.74万户，较上期减少3.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638734554","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638734554?lang=zh_cn&edition=full","pubTime":"2026-05-26 02:29","pubTimestamp":1779733751,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，万邦医药报收于39.65元，下跌2.07%，换手率3.18%，成交量7011.0手，成交额2790.85万元。来自股本股东变化：截至5月20日股东户数环比减少3.36%，户均持股数量上升至8980股。股本股东变化股东户数变动近日万邦医药披露，截至2026年5月20日公司股东户数为7424.0户，较5月8日减少258.0户，减幅为3.36%。户均持股数量由上期的8678.0股增加至8980.0股，户均持股市值为36.91万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600001733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782826579566,"stockEarnings":[{"period":"1week","weight":0.1563},{"period":"1month","weight":0.067},{"period":"3month","weight":-0.0527},{"period":"6month","weight":0.0026},{"period":"1year","weight":-0.0441},{"period":"ytd","weight":0.0026}],"compareEarnings":[{"period":"1week","weight":-0.0214},{"period":"1month","weight":0.0013},{"period":"3month","weight":0.0468},{"period":"6month","weight":0.0265},{"period":"1year","weight":0.1897},{"period":"ytd","weight":0.0265}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽万邦医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"7005人(较上一季度增加1.82%)","perCapita":"4667股","listingDate":"2023-09-25","address":"安徽省合肥市蜀山区高新区火龙地路299号","registeredCapital":"9317万元","survey":" 安徽万邦医药科技股份有限公司的主营业务是药学和临床研究一站式服务。公司的主要产品是临床研究服务、药学研究服务。","listedPrice":67.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万邦医药(301520)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万邦医药(301520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万邦医药,301520,万邦医药股票,万邦医药股票老虎,万邦医药股票老虎国际,万邦医药行情,万邦医药股票行情,万邦医药股价,万邦医药股市,万邦医药股票价格,万邦医药股票交易,万邦医药股票购买,万邦医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万邦医药(301520)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万邦医药(301520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}